Methotrexate Monitoring Guidelines

Introduction to Methotrexate Monitoring

The American College of Rheumatology recommends obtaining CBC with differential, liver function tests, and renal function tests within the first 1-2 months of starting methotrexate therapy, then every 3-4 months thereafter for stable patients 1, 2, 3.

The American College of Rheumatology suggests baseline testing should include complete blood count with differential and platelet count, liver function tests, renal function tests, chest X-ray to establish baseline pulmonary status, hepatitis B and C screening in patients with risk factors for liver disease, and pregnancy testing in women of childbearing potential 4.

For adults taking methotrexate, the recommended monitoring schedule is CBC with differential, liver function tests, and renal function tests within the first 1-2 months after starting methotrexate or after any dose increase, then every 3-4 months for stable patients 1, 2, 3.
The FDA label suggests more frequent monitoring, but rheumatology guidelines recommend every 3-4 months based on low incidence of toxicity in practice 1, 2, 3.

For liver function test elevations, the American College of Rheumatology recommends rechecking in 2-4 weeks for ALT/AST 2-3× upper limit of normal, decreasing or temporarily holding methotrexate for ALT/AST >3× upper limit of normal, and discontinuing methotrexate for persistent elevations >3× upper limit of normal 1, 2, 3, 4, 5.
For hematologic abnormalities, the American College of Rheumatology recommends decreasing or holding methotrexate dose for decreased neutrophil or platelet count, and holding methotrexate immediately and considering leucovorin rescue for significant drop in blood counts 1, 2, 3, 4, 5.

Folic acid supplementation (1-5 mg daily, except on methotrexate dosing day) is strongly recommended to reduce hematologic, hepatic, and gastrointestinal adverse effects 1, 2, 3, 4, 5.

Avoid testing within 2 days after the weekly methotrexate dose, as transient LFT elevations may occur and lead to unnecessary interventions 1, 2, 3, 5.
Wait at least 4 days after dosing to accurately interpret laboratory data 6.